A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/00 (2006.01) A61K 38/57 (2006.01)
Patent
CA 2463738
Methods for prophylactically or therapeutically treating sepsis or septic shock involve administration of tissue factor pathway inhibitor (TFPI) or a TFPI analog to patients suffering from sepsis or other inflammatory conditions. The methods involve the use of continuous intravenous infusion of TFPI or a TFPI analog at low doses to avoid adverse side effects.
L'invention concerne des procédés de prévention ou de traitement d'une maladie infectieuse ou d'un choc septique comportant l'administration d'un inhibiteur de voie d'accès de thromboplastine tissulaire (TFPI) ou d'un analogue TFPI à des patients souffrant d'une maladie infectieuse ou d'autres états inflammatoires. Ces procédés recourent à l'utilisation d'une injection intraveineuse d'un TFPI ou d'un analogue TFPI à faibles doses pour éviter les effets secondaires fâcheux.
Borden Ladner Gervais Llp
Chiron Corporation
Novartis Vaccines And Diagnostics Inc.
LandOfFree
Treatment of sepsis by low dose administration of tissue... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of sepsis by low dose administration of tissue..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of sepsis by low dose administration of tissue... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1861769